Skip to main content

Table 2 Raw data and methodological quality of included trials

From: Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

StudiesRegionSequence generationAllocation concealmentBlindOutcome dataSelective outcome reportingOther sources of biasITTRisk of bias
Yuquan L 2005 [25]Single centerInsufficientUnclearYesNoUnclearYesUnclear risk of bias
Do W 2005 [20]Single centerRandom number table (SPSS)InsufficientUnclearYesNoUnclearYesUnclear risk of bias
Yanhao W 2006 [13]Single centerRandom number table (SPSS)InsufficientUnclearYesNoUnclearYesUnclear risk of bias
Zhijun W [26]Single centerInsufficientUnclearYesNoUnclearYesUnclear risk of bias
Shimeng F 2010 [22]Single centerRandom number table (SPSS)InsufficientUnclearYesNoUnclearYesUnclear risk of bias
Hua Z 2010 [9]Single centerRandom number table (SPSS)InsufficientUnclearYesNoUnclearYesUnclear risk of bias
Xiqiang W 2010 [24]Single centerInsufficientUnclearYesNoUnclearYesUnclear risk of bias
Haiyan C 2015 [10]Single centerRandom number table (SAS)InsufficientUnclearYesNoUnclearYesUnclear risk of bias
Jin L 2015 [12]Single centerInsufficientUnclearYesNoUnclearYesUnclear risk of bias
Tao H 2016 [23]Single centerRandom number table (SPSS)InsufficientClearYesNoUnclearYesLow risk of bias
Chun W 2016 [19]Single centerRandom number table (SPSS)InsufficientClearYesNoUnclearYesLow risk of bias
Hua Z 2017 [21]Single centerRandom number table (SPSS)InsufficientUnclearYesNoUnclearYesUnclear risk of bias
  1. ITT intention-to-treat